Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
They are not a blunt instrument
Oral BPC-157 primarily targets the digestive tract and systemic inflammation, whereas injectable versions are often used for localized musculoskeletal repair
TIGAR, Tp53-induced glycolysis and apoptosis regulator
Proposed Mechanism of Action In theory, the vaccine works by: Delivering mRNA instructions encoding tumour-related antigens Presenting these antigens to immune cells Activating cytotoxic T-cells Directing immune attack toward cancer cells Despite these theoretical mechanisms, several key questions remain unanswered: Which tumour antigens are targeted Which cancer types are included Whether immune activation leads to real tumour shrinkage How long the immune response lasts What side effects may occur
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
